Kara Health Builds JV With Loma Linda University Health

Why It Matters

The deal illustrates how health systems are outsourcing non‑core services through aligned joint ventures, accelerating hospice access while leveraging specialized technology and operational expertise. It signals a scalable growth model that could reshape the hospice industry’s competitive landscape.

Key Takeaways

• Kara Health manages daily operations of Loma Linda Hospice.
• JV targets Inland Empire's Riverside and San Bernardino counties.
• Model replicates successful Palomar Health joint venture.
• Kara plans to launch AI product for hospice care.
• Company pursues ten additional JVs beyond California.

Pulse Analysis

Health systems increasingly turn to joint‑venture structures to fill gaps in services that fall outside their core competencies. By partnering with specialists like Kara Health, institutions such as Loma Linda University Health can extend hospice and palliative‑care capabilities without building those programs from scratch. The JV model aligns incentives—Kara receives operational fees while the health system preserves brand integrity and patient continuity. This collaborative approach is gaining traction as hospitals seek to meet rising end‑of‑life demand while managing cost pressures.

Kara Health’s strategy hinges on a tech‑enabled, high‑touch framework that blends proprietary software, data analytics, and hands‑on clinical support. The company’s first joint venture with Palomar Health proved a growth engine, delivering rapid patient volume increases and operational efficiencies. Building on that success, Kara is preparing to launch an AI‑driven tool designed to predict hospice eligibility and streamline care coordination, promising further differentiation in a crowded market. With ten additional JVs slated across and beyond California, the firm is positioning itself as a national platform for scalable hospice delivery.

For the broader hospice sector, Kara’s JV‑only expansion signals a shift toward partnership‑driven scaling rather than organic growth. Hospitals gain immediate access to best‑in‑class hospice expertise, while Kara leverages existing infrastructure to accelerate market penetration. Investors and policymakers should watch how these alliances affect reimbursement dynamics, patient outcomes, and competitive pressures, as the model could become a blueprint for other specialty services seeking rapid, technology‑focused expansion.